Context Therapeutics Inc (US: CNTX) — Healthcare · Share Price, Chart & Market Data
About: Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of solid tumors. The company's product candidate includes CTIM-76, a Claudin 6 (CLDN6) x CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. It has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.26 (-2.59%)
CNTXContext Therapeutics Inc
Loading watchlist status…
Trade CNTX now
Context Therapeutics Inc share price
CNTX price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 9:28 am GMT+0
CNTX price performance
-4.641%
5D
-12.741%
1M
45.806%
YTD
140.4%
1Y
CNTX price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 9:28 am GMT+0
CNTX details
CNTX Market Signals